Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Aug;18(4):632-638.
doi: 10.1007/s12328-025-02156-5. Epub 2025 Jun 8.

Diffuse dark brown discoloration of gastric fundic gland mucosa following proton pump inhibitor therapy

Affiliations
Case Reports

Diffuse dark brown discoloration of gastric fundic gland mucosa following proton pump inhibitor therapy

Takashi Ihara et al. Clin J Gastroenterol. 2025 Aug.

Abstract

Herein, we report a case in which diffuse dark brown discoloration was observed throughout the gastric fundic gland mucosa on endoscopy 2 years after the initiation of proton pump inhibitor (PPI) therapy. In addition, scattered dark brown spots were observed within the area of diffuse discoloration. These lesions were significantly more pronounced on the Texture and Color Enhancement Imaging mode 1. These changes were not observed before the initiation of PPI therapy or in the antrum after PPI administration. Biopsy specimens from the discolored mucosa revealed lipofuscin granules in the cytoplasm of the parietal cells. These findings suggest that the discoloration was a result of the deposition of lipofuscin due to the action of PPI on parietal cells. To the best of our knowledge, these findings have not been previously reported and are distinct from those of black spots and gastric pseudomelanosis. We believe that these new findings offer valuable insights into gastric mucosal changes associated with PPI therapy.

Keywords: Dark brown spot; Diffuse dark brown discoloration; Lipofuscin; Pigmentation; Proton pump inhibitor.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors have no conflict of interest.

Similar articles

References

    1. Shanika LGT, Reynolds A, Pattison S, et al. Proton pump inhibitor use: systematic review of global trends and practices. Eur J Clin Pharmacol. 2023;79:1159–72.
    1. Vaezi MF, Yang YX, Howden CW. Complications of proton pump inhibitor therapy. Gastroenterology. 2017;153:35–48.
    1. Kato M. PPI-related gastropathy. Kyoto classification of gastritis. 2nd ed. Tokyo: Nihon Medical Center; 2018. p. 96–9 (in Japanese).
    1. Ayaki M, Haruma K. Black spot. Kyoto classification of gastritis. 3rd ed. Tokyo: Nihon Medical Center; 2023. pp.106–7 (in Japanese).
    1. Hatano Y, Haruma K, Ayaki M, et al. Black spot, a novel gastric finding potentially induced by proton pump inhibitors. Intern Med. 2016;55:3079–84.

Publication types

LinkOut - more resources